American Funds Capital World Growth and Income A (CWGIX) a Zacks Ranked #2 (Buy) was incepted in March 1993 and is managed by Capital Research and Management Company. CWGIX’s main objective is to provide long-term growth of capital with current income by investing in established, growing companies all over the world, including the United States. CWGIX invests primarily in blue chip stocks issued by companies in the world's largest stock markets. CWGIX is conservatively managed and focuses on established companies that pay regular dividends. CWGIX invests in common stocks, government and corporate bonds, and cash and equivalents. This Global-Equity product, as of the last filing, allocates their fund in six major groups; Foreign Stock, Large Value, Large Growth, Emerging Market, Small Growth and Precious Metal. Further, as of the last filing, Amgen Inc, Novartis AG and Alphabet Inc were the top holdings for CWGIX. American Funds Capital World Growth and Income A, managed by American Funds, carries an expense ratio of 0.77%. Moreover, CWGIX requires a minimal initial investment of $250. CWGIX has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 5.90% and 5 year 6.08%. To see how this fund performed compared in its category, please click here. CWGIX’s performance, as of the last filing, when compared to funds in its category was in the top 47% in 1 year, top 46% over the past 3 years, and in the 41% over the past 5 years. Zacks Premium To see the Zacks Mutual Fund Rank for the funds you’re interested in —plus, gain access to the Zacks Rank for your stocks and ETFs; Premium Screens; Equity Research Reports; Focus List portfolio of 50-longer-term stocks and more— start your 30-day free trial to Zacks Premium. View All Zacks #1 Ranked Mutual FundsWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (CWGIX): Fund Analysis Report To read this article on Zacks.com click here. Zacks Investment Research